Argenica Therapeutics
Argenica Therapeutics

Argenica Therapeutics Information

Contact top employees from Argenica Therapeutics

Summary

Argenica Therapeutics(ASX: AGN) is developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. <...Show more

Organization Website

argenica.com.au

Social Links

linkedIn

Industries

Headquarters Location

Nedlands, Perth, Western Australia, 6009 AU

Employees Size

1-10 employees

Founded

2019

Competitors

Founded
Type
Employees
Revenue
Funding
2011Privately
Held
25 - 100 16M $20.2M
2010Privately
Held
100 - 250 39.4M $0
2015Privately
Held
1 - 25 < 1M $0
2017Privately
Held
1-10 - $-

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Argenica Therapeutics shows a diverse range of experience levels:
10% have been with the company for less than 1 year30% for 1–2 years20% for 3–4 years40% for 5–7 years
Ex-employees positions
In Company
In New Company
Contact top employees from Argenica Therapeutics
Meghan Thomas
Vice President of Clinical and Regulatory Development
View
Liz Dallimore
CEO & Managing Director
View
Sharon Hanegraaf
Vice President Regulatory Affairs
View
Stuart Gribble
Vice President of Product Development
View
Dianne Angus
Non Executive Chair
View
Orla McCabe
Pharmaceutical Development Project Manager
View

FAQ

Argenica Therapeutics operates in the Pharma industries. More details can be found on the official website: argenica.com.au.
The headquarters of Argenica Therapeutics are located in Nedlands, Perth, Australia.
Argenica Therapeutics currently employs 1-10 people.
Well-known competitors of Argenica Therapeutics include Halo Labs, Longevity Biotech, Context Therapeutics and Avisi Technologies.
BACK TO TOP